Ever Source Wealth Advisors, LLC Cytokinetics Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 51 shares of CYTK stock, worth $2,030. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51
Previous 38
34.21%
Holding current value
$2,030
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CYTK
# of Institutions
401Shares Held
115MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$584 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$474 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$428 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$246 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$113 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.75B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...